AIM-HI Accelerator Fund

Venture Capital Rockville, United States ·Founded 2019

Overview

AIM-HI Accelerator Fund is a 501(c)(3) non-profit organization established in 2019 by the National Foundation for Cancer Research. Its mission is to bridge the gap between research breakthroughs and clinical trials, aiming to develop innovative cancer therapies and technologies that can save patients' lives. The organization focuses on providing seed funding to early-stage oncology and STEM companies, addressing the 'Valley of Death' where traditional venture capital is often unavailable. The fund's strategy involves a venture philanthropy approach, combining investment funding with coaching, advising, and building a continuous global network. Since its inception, AIM-HI has supported approximately 30 start-up oncology and STEM companies. The organization also hosts the AIM-HI Venture Competition, a program designed to support scientist-entrepreneurs in the oncology arena by offering investment funding alongside mentorship and access to a global network. AIM-HI's philosophy centers on creating a sustainable model for cancer research funding and STEM entrepreneurship. By recycling philanthropic capital, the fund aims to magnify social impact and improve the sustainability of social enterprises. This approach ensures that successful portfolio investments are reinvested into promising oncology discoveries and startups, fostering a self-perpetuating cycle of innovation and impact in cancer research and treatment.

Investment Focus

  • Early-stage oncology and STEM startups seeking seed funding

Portfolio Companies

March BiosciencesDegron Therapeutics

Get the full list of 54,000+ investors

AIM-HI Accelerator Fund and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about AIM-HI Accelerator Fund

What sectors does AIM-HI Accelerator Fund invest in?

AIM-HI Accelerator Fund invests in Healthcare and Biotechnology, and is based in Rockville, United States. AIM-HI Accelerator Fund is listed as a venture capital in the ConnectSafely investor database.

What stage does AIM-HI Accelerator Fund invest at?

AIM-HI Accelerator Fund backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 1M - 5M.

Which regions does AIM-HI Accelerator Fund invest in?

AIM-HI Accelerator Fund invests across United States.

Who are the partners at AIM-HI Accelerator Fund?

Team members listed for AIM-HI Accelerator Fund include Sujuan Ba (Ph.D Co-Founder & Chief Executive Officer) and Charlie Weatherspoon (Co-founder).

What companies has AIM-HI Accelerator Fund invested in?

AIM-HI Accelerator Fund's portfolio includes March Biosciences and Degron Therapeutics.

How do I contact AIM-HI Accelerator Fund?

AIM-HI Accelerator Fund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database